BHVN Overview
Upcoming Projects (BHVN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (BHVN)
-
Discussing the topline data from the phase 3 BHV4157-206 clinical trial of Troriluzole in patients with SCA.
Ticker: BHVN
Executed On: Nov 08, 2024 at 01:30 PM EST -
Reviewing the standard of care for epilepsy and the potential of Biohaven's BHV-7000
Ticker: BHVN
Executed On: Sep 15, 2023 at 01:15 PM EDT -
Discussing the potential of BHV-4157 (troriluzole) and the results from the Phase 3 BHV4157-206 Study in adult subjects with spinocerebellar ataxia.
Ticker: BHVN
Executed On: Jul 24, 2023 at 02:30 PM EDT -
Discussing the potential of Biohaven Pharmaceutical's troriluzole, a tripeptide prodrug formulation of riluzole taken orally to treat OCD, which has recently failed it's phase 2/3 trial.
Ticker: BHVN
Executed On: Jun 07, 2023 at 01:00 PM EDT -
A third look: Digging into the data on Biohaven's potential epilepsy treatment BHV-7000 (formerly KB-3061) presented at ASENT 2023.
Ticker: BHVN
Executed On: May 03, 2023 at 12:00 PM EDT -
A second look: Digging into the data on Biohaven's potential epilepsy treatment BHV-7000 (formerly KB-3061) presented at ASENT 2023.
Ticker: BHVN
Executed On: Apr 28, 2023 at 09:00 AM EDT -
Digging into the data on Biohaven's potential epilepsy treatment BHV-7000 (formerly KB-3061) presented at ASENT 2023.
Ticker: BHVN
Executed On: Apr 24, 2023 at 08:30 AM EDT -
Overview of Migraine therapies - Biohaven - 2nd look
Tickers: BHVN, ABBV
Executed On: Jan 07, 2022 at 11:00 AM EST -
Overview of Migraine therapies - Biohaven
Tickers: BHVN, ABBV
Executed On: Jan 03, 2022 at 02:00 PM EST
Upcoming & Overdue Catalysts (BHVN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (BHVN)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
